BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buckinx A, De Bundel D, Kooijman R, Smolders I. Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy. Biomedicines 2022;10:53. [DOI: 10.3390/biomedicines10010053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu J, Meng Y, Xu F, Wu Q, Wang C. The viral and inflammation hypothesis of epileptic seizures based on bioinformatic study of circulating miRNAs and peripheral whole-blood mRNAs of adult epilepsy patients. Front Neurol 2022;13:909142. [DOI: 10.3389/fneur.2022.909142] [Reference Citation Analysis]
2 Costa A, Lo Barco T, Spezia E, Conti V, Roli L, Marini L, Minghetti S, Caramaschi E, Pietrangelo L, Pecoraro L, D’achille F, Accorsi P, Trenti T, Melani F, Marini C, Guerrini R, Darra F, Bergonzini P, Biagini G. Prospective Evaluation of Ghrelin and Des-Acyl Ghrelin Plasma Levels in Children with Newly Diagnosed Epilepsy: Evidence for Reduced Ghrelin-to-Des-Acyl Ghrelin Ratio in Generalized Epilepsies. JPM 2022;12:527. [DOI: 10.3390/jpm12040527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bukhari SNA. An insight into the multifunctional role of ghrelin and structure activity relationship studies of ghrelin receptor ligands with clinical trials. Eur J Med Chem 2022;235:114308. [PMID: 35344905 DOI: 10.1016/j.ejmech.2022.114308] [Reference Citation Analysis]